Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/64217
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGiram, Dipak-
dc.contributor.authorShrivastava, Tanvi-
dc.contributor.authorDas, Arijit-
dc.date.accessioned2024-07-05T11:38:05Z-
dc.date.available2024-07-05T11:38:05Z-
dc.date.issued2024-07-
dc.identifier.issn0022-4456 (Print); 0975-1084 (Online)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/64217-
dc.description711-720en_US
dc.description.abstractThe present study focused on the photo catalytic degradation of Ciprofloxacin (CP) using ultrasonically synthesized TiO2 and Fe-doped TiO2 (1 wt%) nanoparticles under sunlight. The synthesized nanoparticles were extensively characterized using XRD, FTIR, FESEM and EDS techniques. XRD analysis revealed that Fe+3 ions were successfully incorporated into TiO2, and both TiO2 and Fe-doped TiO2 nanoparticles contained only anatase phase. The average crystallite size of synthesized nanoparticles was estimated to be in the range of 4-6 nm. The EDS analysis has confirmed the existence of Fe in the sample of Fe-doped TiO2. The CP degradation study was performed and compared using synthesized nanoparticles. The optimized value of the degradation was investigated by varying experimental parameters, namely, irradiation time, catalyst dosage, initial CP concentration, and pH. Fe-doped TiO2 nanoparticles outperformed compared to pure TiO2 nanoparticles for CP degradation. The maximum CP degradation was achieved around 87% at a catalyst dosage of 30 mg, initial CP concentration of 10 ppm, pH of 5, and irradiation time of 150 minutes.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR,Indiaen_US
dc.sourceJSIR Vol.83(7) [July 2024]en_US
dc.subjectAnatase phaseen_US
dc.subjectUltrasonically synthesizeden_US
dc.subjectPhotocatalysisen_US
dc.subjectNanocompositeen_US
dc.subjectWastewater treatmenten_US
dc.titleUltrasound Assisted Synthesis of Fe Doped TiO2 Nanoparticles for Enhanced Photocatalytic Degradation of Ciprofloxacinen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/jsir.v83i7.874en_US
Appears in Collections:JSIR Vol.83(07) [July 2024]

Files in This Item:
File Description SizeFormat 
JSIR 83(07) 711-720.pdf1.7 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.